Iversen, LisaSivasubramaniam, SelvarajLee, Amanda JFielding, Shona AHannaford, Philip C2018-02-092018-02-092017-06Iversen, L, Sivasubramaniam, S, Lee, A J, Fielding, S A & Hannaford, P C 2017, 'Lifetime cancer risk and combined oral contraceptives : the Royal College of General Practitioners’ Oral Contraception Study', American Journal of Obstetrics and Gynecology, vol. 216, no. 6, pp. 580.e1-580.e9. https://doi.org/10.1016/j.ajog.2017.02.0020002-9378ORCID: /0000-0002-4865-9061/work/159078258http://hdl.handle.net/2164/10010Funding: The study has received funding from the Royal College of General Practitioners, Medical Research Council, Imperial Cancer Research Fund, British Heart Foundation, Schering AG, Schering Health Care Ltd, Wyeth Ayerst International, Ortho Cilag and, Searle. None of these funders have contributed to the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review or approval of the manuscript.9315986engSDG 3 - Good Health and Well-beingcanceroral contraceptioncohort studyRG Gynecology and obstetricsGeneral MedicineBritish Heart FoundationMedical Research Council (MRC)RGLifetime cancer risk and combined oral contraceptives : the Royal College of General Practitioners’ Oral Contraception StudyJournal article10.1016/j.ajog.2017.02.0022166